Internal Medicine, Medical Oncology · Boston, MA
NPI
1235544362
Since 2014
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
830 Harrison Avenue, 3rd Fl, Moakley Bldg
Boston, MA, 02118
Phone (617) 638-6428
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
148 services
Medicare patients, 2024
86
Average age 74
Drug cost, 2024
$1.3M
338 prescriptions
Company payments, 2024
$4,319
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hussein Assi was code 99214 (office e&m - established), 40 times for 24 patients. In total Hussein Assi billed 148 services in 13 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 40 | 24 | $71.06 | $2,842 |
| 99215 Office E&M - Established | Facility | 38 | 18 | $102.04 | $3,878 |
| 99223 Hospital E&M - Initial | Facility | 30 | 30 | $140.08 | $4,202 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $108.55 | $1,194 |
By year: 2022 $39K for 325 services; 2023 $34K for 309 services; 2024 $15K for 148 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hussein Assi prescribed most often to Medicare patients was Dexamethasone, with 86 prescriptions and refills. In total Hussein Assi wrote 338 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dexamethasone Generic | 86 | 86 | 19 | $504 |
| Olanzapine Generic | 46 | 46 | Under 11 | $191 |
| Prochlorperazine Maleate Generic | 34 | 34 | 19 | $391 |
| Lonsurf Trifluridine/Tipiracil Hcl | 22 | 22 | Under 11 | $289K |
| Eliquis Apixaban | 18 | 38 | Under 11 | $21K |
| Gavreto Pralsetinib | 13 | 13 | Under 11 | $256K |
| Everolimus Generic | 12 | 12 | Under 11 | $293K |
| Loperamide Loperamide Hcl | 12 | 12 | Under 11 | $81.21 |
Brand drugs: 74 claims; generic drugs: 264 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Hussein Assi $4,319 ($4,319 in general payments such as food, travel and fees) from 1 company. The largest payer was Exelixis Inc. with $4,319.
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. EXEL | 12 | $4,319 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.